tirzepatide better than semaglutide vs. Semaglutide: Understanding Your Weight Loss Medication Options Tirzepatide vs. semaglutide for weight

In the non-T2DM population, the differences with semaglutide 2.4 mg versus comparators ranged from 3.35% (CrI 5.85, 0.80) with phentermine 15 mg/topiramate 92 mg to 12.43% (CrI 14.51, 10.38) with placebo/control

Consulte a su mdico o farmacutico para indicaciones, dosificacin y contraindicaciones

A 2023 study shows that semaglutide, a GLP-1 agonist, reduced cardiovascular events by 20%, while other studies show that the Mediterranean diet can reduce heart disease by up to 30% for those at risk 7,8,9

However, research on the cardiovascular effects of GIP is still relatively limited, and the similarities and synergistic effects between GIP and GLP-1 require further exploration ( 5.2 Prospective clinical trial progress and results of tirzepatide in the treatment of type 2 diabetes with cardiovascular disease Currently, two significant cardiovascular outcome trials for tirzepatide are underway (or have recently concluded), including SURPASS-CVOT and SUMMIT

You stay here for the remainder of your treatment, whether that is months or years